289 related articles for article (PubMed ID: 32892987)
1. Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion.
Patti G; Sticchi A; Verolino G; Pasceri V; Vizzi V; Brscic E; Casu G; Golino P; Russo V; Rapacciuolo A; Boccuzzi G; Mangieri A; Pagnotta PA; Colombo A;
Am J Cardiol; 2020 Nov; 134():83-90. PubMed ID: 32892987
[TBL] [Abstract][Full Text] [Related]
2. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
[TBL] [Abstract][Full Text] [Related]
3. Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens.
Vignali L; Gurgoglione FL; Barocelli F; Cattabiani MA; Solinas E; Maini A; Tadonio I; Benatti G; Pelà G; Coli S; Ardissino D; Niccoli G
Int J Cardiol; 2023 Jan; 371():92-99. PubMed ID: 36181948
[TBL] [Abstract][Full Text] [Related]
4. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
[TBL] [Abstract][Full Text] [Related]
5. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device.
Sedaghat A; Schrickel JW; Andrié R; Schueler R; Nickenig G; Hammerstingl C
JACC Clin Electrophysiol; 2017 Jan; 3(1):71-75. PubMed ID: 29759698
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation.
Dannenberg L; Mourikis P; Naguib D; Zako S; Helten C; M'Pembele R; Trojovsky K; Konsek D; Wolff G; Brockmeyer M; Schulze V; Levkau B; Hohlfeld T; Zeus T; Kelm M; Polzin A
Int J Cardiol; 2019 Jan; 275():95-100. PubMed ID: 30509374
[TBL] [Abstract][Full Text] [Related]
7. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure.
Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ
Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344
[TBL] [Abstract][Full Text] [Related]
10. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness.
Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B
Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis Comparing the Safety and Efficacy of Single vs Dual Antiplatelet Therapy in Post Transcatheter Aortic Valve Implantation Patients.
Ullah W; Zghouzi M; Ahmad B; Biswas S; Zaher N; Sattar Y; Pacha HM; Goldsweig AM; Velagapudi P; Fichman DL; Prasad A; Alraies MC
Am J Cardiol; 2021 Apr; 145():111-118. PubMed ID: 33454348
[TBL] [Abstract][Full Text] [Related]
12. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
[TBL] [Abstract][Full Text] [Related]
13. Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk.
Mhanna M; Beran A; Al-Abdouh A; Jabri A; Al-Aaraj A; Sajdeya O; Abuhelwa Z; Khokher W; Bhuta S; Burmeister CJ; Eltahawy EA
Curr Probl Cardiol; 2022 Sep; 47(9):101269. PubMed ID: 35644502
[TBL] [Abstract][Full Text] [Related]
14. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
Bergmann MW; Ince H; Kische S; Schmitz T; Meincke F; Schmidt B; Foley D; Betts TR; Grygier M; Protopopov AV; Stein KM; Boersma LVA
EuroIntervention; 2018 Apr; 13(17):2003-2011. PubMed ID: 29313819
[TBL] [Abstract][Full Text] [Related]
15. Propensity-matched comparison of antiplatelet versus anticoagulant after left atrial appendage closure with the Watchman.
Liu XX; Kleinecke C; Busch S; Allakkis W; Mohrez Y; Cheikh-Ibrahim M; Mahnkopf C; Brachmann J; Schnupp S; Gloekler S; Yu J; Ma C
Pacing Clin Electrophysiol; 2020 Nov; 43(11):1242-1251. PubMed ID: 32779203
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
[TBL] [Abstract][Full Text] [Related]
18. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
19. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
[TBL] [Abstract][Full Text] [Related]
20. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
